News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Sun Pharmaceutical Industries Ltd (SUNPHARMA.NS) To Buy Struggling Ranbaxy Laboratories (RANBAXY.BO) In $3.2-Billion Landmark Transaction



4/7/2014 6:14:42 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

TOKYO/MUMBAI, April 7 (Reuters) - India's Sun Pharmaceutical Industries Ltd has agreed to buy generic drugmaker Ranbaxy Laboratories Ltd for $3.2 billion, betting it can fix factory quality glitches that plagued the current owner, Japan's Daiichi Sankyo Co, and got Ranbaxy India-made drugs barred from the United States.

Help employers find you! Check out all the jobs and post your resume.

Read at Reuters
Read at Market Watch
Read at Boston Herald
Read at Business Week
Read at New York Times


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES